HealthTech BioActives (HTBA), a global leader in the manufacture of citrus flavonoids and active forms of vitamin B12, has announced the completion of a €25 million investment project to modernize its research, development and manufacturing center in Murcia, Spain. The initiative included the construction of a new state-of-the-art production plant, which was officially inaugurated on Tuesday 28 January, making HTBA the only company in Europe capable of producing all active forms of vitamin B12, reinforcing its status as a leader in the industry.

The multi-million-euro project aimed to introduce advanced manufacturing processes and sustainability measures to strengthen HTBA’s position as a prominent player in the sector and reduce its environmental footprint. To this end, the investment also involved the modernization of the company’s existing citrus flavonoid production plant, enabling further development of HTBA’s unique, patented manufacturing process for a specific type of flavonoid, diosmin – an ingredient that can help promote blood circulation and address vascular discomfort. This new production process replaces artificial solvents with water. As a result, HTBA is now the only company in the world capable of manufacturing diosmin without the use of artificial solvents.

"Our origins in citrus flavonoids and vitamin B12 date back more than 45 years and this innovation project marks a huge milestone for HTBA, demonstrating our unwavering dedication to producing high-quality, environmentally responsible products on a global scale,” comments Alexandre Valls-Coma, Chief Executive Officer of HTBA. “Through this significant investment, we’re not only reinforcing our global leadership in the production of active forms of vitamin B12 and citrus flavonoids, but we’re also furthering our commitment to upholding the highest standards in sustainability and innovation."

In line with the company’s ongoing commitment to sustainability, the new and upgraded facilities harness advanced technology and automation systems that support the use of renewable energy and optimize resource consumption. Overall, the investment has enabled 98% of waste generated to be recovered, revalued or recycled.

To learn more about HTBA’s range of citrus flavonoids and active forms of vitamin B12 for the pharmaceutical and nutraceutical market, click here.

About HTBA

HTBA is a science-based global leader in the manufacturing and commercialization of citrus flavonoids and active forms of vitamin B12 for the pharmaceutical, nutraceutical, food and beverage, and animal nutrition sectors. For over forty-five years, the company has pioneered the development of new processes to create high-quality, naturally derived ingredients that support the health of people and animals, all while protecting the environment.

Headquartered in Barcelona, Spain, HTBA produces ingredients of unsurpassed quality at its state-of-the-art manufacturing facility in Murcia, Spain. Plus, with ideation centers located in Spain and at its North American operations center in Ohio, the company is well-positioned to understand and quickly respond to global end-user consumer demand.

Media contacts   
For more information or to arrange an interview, please contact:
Cristina Martínez 
Marketing Manager 

HTBA                            
cmartinez@htba.com                              
+34 935044408                                      

Kate Spurdens 
Senior Account Executive 
BDB (Barrett Dixon Bell) 
htba@bdb.co.uk  
+44 1619254700 

Report Abuse